Funding for this research was provided by:
Japan Society for the Promotion of Science (26461945)
Text and Data Mining valid from 2019-08-06
Received: 7 March 2019
Accepted: 12 July 2019
First Online: 6 August 2019
Ethics approval and consent to participate
: This study was approved by the institutional review board of Osaka University Hospital (protocol #14106 and/or #14111), and written informed consent was obtained from each patient.
: Consent for publication of research data was included in the consent forms and approved by the institutional review board of Osaka University Hospital. Images from tissue specimens of patients are entirely unidentifiable.
: Masafumi Shimoda has received honoraria from Chugai, Eisai, Novartis, and Takeda. Shinzaburo Noguchi has been an advisor for Taiho, AstraZeneca, and Novartis and has received research funding for other studies from AstraZeneca, Sysmex, Novartis, Chugai, Daiichi-Sankyo, Kyowa-Kirin, Takeda, Pfizer, Ono, Taiho, and Eisai and honoraria from AstraZeneca, Novartis, Pfizer, Chugai, Takeda, Sysmex, Nippon Kayaku, and Ono. The other authors declare that they have no competing interests.